Biotech Archives - Page 22 of 795

1 minute read

Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy

May 28, 12:03 PM

Asahi Kasei's $1.1 billion acquisition of Calliditas Therapeutics offers 208 SEK per share in cash. The deal boosts Asahi Kasei's global presence in immunology and renal disease markets, aligning with its strategic growth and expansion in the U.S. and Europe.

CALT

2 minute read

Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System

By Vandana Singh

May 28, 11:59 AM

Novo Nordisk retains around 60% of the list price for its diabetes and obesity medications, Ozempic and Wegovy, after rebates and fees.

NVO

1 minute read

Merck’s Multi-Billion Cancer Drug Keytruda Aces Late-Stage Lung Cancer Study

By Vandana Singh

May 28, 10:24 AM

Merck's KEYNOTE-522 trial shows Keytruda combined with chemotherapy significantly improves overall survival in high-risk early-stage triple-negative breast cancer patients compared to chemotherapy alone.

MRK

1 minute read

Why Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday?

By Vandana Singh

May 28, 9:39 AM

Corcept Therapeutics announced the GRACE Phase 3 trial results for relacorilant in Cushing's syndrome, showing significant improvements in hypertension and hyperglycemia.

CORT

2 minute read

Ozempic Maker Novo Nordisk’s Increasing Influence On Denmark’s Employment Raises Economic Concerns

By Benzinga Neuro

May 28, 9:28 AM

The updated employment figures have heightened concerns about Denmark's economy becoming excessively dependent on Novo.

NVO

1 minute read

Bausch + Lomb Presents New Scientific Data And Evaluations Featuring Consumer, Vision Care And Pharmaceutical Products At Optometry’s Meeting June 19-22, 2024

By Benzinga Newsdesk

May 28, 9:04 AM

15 ePosters and In-Person Presentations Will Include Clinical Data on Blink™ NutriTears® Supplement for Dry Eyes, Blink® Triple Care Lubricating Eye Drops and MIEBO® (Perfluorohexyloctane Ophthalmic

BLCO

1 minute read

Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?

By Vandana Singh

May 28, 8:58 AM

Insmed shares surged after topline results from the ASPEN Phase 3 study of brensocatib for non-cystic fibrosis bronchiectasis.

INSM

1 minute read

NRx Pharmaceuticals Presents Landmark Trial Of NRX-101 In Suicidal Bipolar Depression At The ASCP Annual Meeting: NRX-101 Is The First Oral Antidepressant Demonstrated To Reduce Suicidality In Bipolar Depression

By Benzinga Newsdesk

May 28, 8:47 AM

Poster presentation of "A Randomized, Double-Blind Controlled Comparison of NRX-101 (D-cycloserine/lurasidone) to Lurasidone for Adults with Bipolar Depression and Subacute Suicidal Ideation or Behavior"NRX-101

NRXP

1 minute read

Scholar Rock Presents New Data From SRK-181 Phase 1 DRAGON Trial At The ASCO Annual Meeting

By Benzinga Newsdesk

May 28, 8:14 AM

- Updated safety and efficacy results on SRK-181 will be featured in an oral presentation on Monday, June 3rd, at 1:50 p.m CDT/2:50 p.m. EDT- Company will host conference call to discuss the data on Tuesday, June 4th at

SRRK

1 minute read

NeoGenomics Introduces Comprehensive Lung Solution & Feature Hematopathology Services At ASCO

By Benzinga Newsdesk

May 28, 8:10 AM

NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology

NEO